NAD+ 500MG
NAD+ (Nicotinamide Adenine Dinucleotide) is a crucial coenzyme involved in various biochemical processes, predominantly in cellular metabolism and energy production. This product provides a purified form of NAD+ in a standardized 500mg dose, intended for use in academic and industrial research applications.
Research Context
NAD+ is a naturally occurring molecule found in all aerobic organisms, playing a pivotal role in redox reactions within cells. It is a key component in the electron transport chain and is essential for the proper functioning of enzymes involved in energy production, DNA repair, and cellular signaling pathways. Over the past several decades, extensive research has explored NAD+ supplementation as a potential therapeutic agent in both human and animal studies, though its applications are strictly confined to controlled experimental environments.
Research Overview
NAD+ has been extensively studied within research settings due to its role in aging processes, metabolic health, and disease pathogenesis. Initial findings highlighted its involvement in NAD+ biosynthesis pathways, where it is converted from precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). The molecule is particularly notable for its participation in the process of poly ADP-ribose polymerase (PARP) activation, which influences DNA damage repair mechanisms. Additionally, NAD+ levels are often analyzed in conjunction with other biomarkers to assess cellular stress responses and mitochondrial function.
Key Research Focus Areas
- Cellular Metabolism and Energy Production:
NAD+ is a fundamental substrate for enzymes like CD38 and NADsynthetase, which regulate its levels within cells. Research has explored the impact of NAD+ depletion on mitochondrial efficiency and ATP production, particularly in conditions such as aging and metabolic disorders. - DNA Repair and Cellular Stress Response:
NAD+-dependent enzymes, such as PARP-1, are critical for repairing DNA damage. Studies have investigated how NAD+ levels influence the efficacy of cellular stress responses, including those triggered by oxidative stress and genotoxic agents. - Aging and Longevity Research:
NAD+ has been a focal point in aging research, as its decline with advancing age correlates with reduced cellular repair capacity. Research has examined NAD+-boosting interventions in model organisms, aiming to understand mechanisms underlying lifespan extension. - Neurodegenerative Disease Mechanisms:
NAD+ plays a role in synaptic function and neuroprotection. Preclinical studies have explored its potential role in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, where NAD+ metabolism is often dysregulated. - Pharmacological and Synthetic Investigations:
The development of NAD+-mimetic compounds and synthetic precursors (e.g., NMN, NMNA) has been a major research endeavor. These studies are aimed at improving the bioavailability and stability of NAD+ derivatives for potential therapeutic applications in research settings.
Product Formulation and Stability
This product is formulated with high-purity NAD+ in a stable, lyophilized powder format. The 500mg dose is designed to provide a measurable amount of NAD+ for use in biochemical assays, cellular models, or other experimental applications. The product is intended for use in controlled laboratory conditions and may be reconstituted with appropriate buffers or solvents as required by the researcher.
Important Safety and Compliance Notice
This product is for research purposes only and is not intended for human or animal consumption. The use of NAD+ in research settings should be conducted in accordance with established protocols and ethical guidelines. Researchers are advised to consult relevant regulatory authorities and institutional review boards regarding the appropriate handling, storage, and disposal of biochemical materials. Misuse or unauthorized distribution of this product is prohibited.
For research use only. Not for human or animal consumption.





Reviews
There are no reviews yet.